Search results for "interferon"

showing 10 items of 963 documents

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C

2001

This study aimed to characterise the immune mechanisms relevant to viral clearance in interferon (IFN)-alpha-treated chronic hepatitis C virus (HCV) infection. Proliferative responses of peripheral blood mononuclear cells from sustained complete IFN-alpha therapy responders (n = 8), nonresponders (n = 13), untreated patients (n = 10), and healthy controls (n = 5) were measured retrospectively upon stimulation with recombinant HCV-antigens (core, helicase, NS3, NS4, and NS5) and the secretion of IFN-gamma and interleukins (IL-4, IL-5, IL-10, and IL-12) were tested by ELISA. Furthermore, IFN-gamma as well as IL-10 secreting CD4+ T cells were quantitated by intracellular cytokine staining. Ant…

Interleukin 2biologybusiness.industrymedicine.medical_treatmentvirus diseasesVirologyImmunoglobulin GInterleukin 10Infectious DiseasesImmune systemCytokineInterferonVirologyImmunologybiology.proteinMedicineInterferon gammaAntibodybusinessmedicine.drugJournal of Medical Virology
researchProduct

Monocyte Interleukin-1 Secretion Is Regulated by the Sequential Action of γ-Interferon and Interleukin-2 Involving Monocyte Surface Expression of Int…

1989

Interleukin-1 (IL-1) is a polypeptide synthesized as a high-mol.-wt. precursor and subsequently secreted after proteolytic cleavage to 17500-dalton active forms in murine [1] and human cells [2]. Recently, cDNAs for murine [3] and for two distinct human IL-1 species, IL-1α and IL- 1β, have been isolated, sequenced, and cloned [2, 4].

Interleukin 2medicine.anatomical_structureChemistryMonocytemedicineInterleukinSurface expressionSecretionγ interferonCleavage (embryo)ReceptorMolecular biologymedicine.drug
researchProduct

Effect of isoprinosine on IL-2, IFN-γ and IL-4 production in vivo and in vitro

1991

The effects of an immunopotentiating drug, isoprinosine, on the splenocytes of BALB/c mice to produce cytokines were investigated. Isoprinosine enhanced IL-2 production, upregulating the expression of IL-2 receptor in vitro. It also significantly increased the IFN-gamma secretion and decreased the IL-4 production in vivo. The significance of these findings in terms of immune regulation is discussed.

Interleukin 2medicine.drug_classImmunologyIn Vitro TechniquesBiologyImmunostimulantInterferon-gammaMiceT-Lymphocyte SubsetsIn vivoInosine PranobexmedicineSplenocyteAnimalsInterferon gammaReceptorInterleukin 4PharmacologyMice Inbred BALB CIn vitroImmunologyInterleukin-2FemaleInterleukin-3Interleukin-4Spleenmedicine.drugInternational Journal of Immunopharmacology
researchProduct

Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors

1990

Purified protein derivative reactive T cell lines were established under identical conditions with the exception that different lymphokines, namely interleukin (IL) 2 and IL 4 were employed as growth factors. IL 2 favored the development of T cell lines (LNC.2) which upon activation by concanavalin A (Con A) secreted predominantly lymphokines characteristic of TH1 cells. By contrast, T cell lines established with the aid of IL 4 as growth factor (LNC.4) produced mainly lymphokines representative of TH2 cells. Apart from their pattern of lymphokine secretion LNC.2 and LNC.4 T cells were found to differ in their proliferative response to lymphokines and Con A. LNC.2 T cells proliferated only …

Interleukin 2medicine.medical_specialtyT-Lymphocytesmedicine.medical_treatmentT cellImmunologyEnzyme-Linked Immunosorbent AssayIn Vitro TechniquesBiologyCell LineInterferon-gammaMiceInterleukin 21Internal medicinemedicineAnimalsImmunology and AllergyRNA MessengerInterleukin 4Mice Inbred BALB CInterleukin-6LymphokineInterleukinT lymphocyteBlotting NorthernCulture MediaEndocrinologyCytokinemedicine.anatomical_structureInterleukin-2Interleukin-3Interleukin-4Interleukin-5Cell Divisionmedicine.drugEuropean Journal of Immunology
researchProduct

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

2022

Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease (CVD) often cluster together as "Cardiometabolic Disease" (CMD). Just under 50% of patients with CMD increased the risk of morbidity and mortality right from the beginning of the COVID-19 pandemic as it has been reported in most countries affected by the SARS-CoV2 virus. One of the pathophysiological hallmarks of COVID-19 is the overactivation of the immune system with a prominent IL-6 response, resulting in severe and systemic damage involving also cytokines such as IL2, IL4, IL8, IL10, and interferon-gamma were considered strong predictors of COVID-19 severity. Thus, in this mini-review, we try to describe the…

Interleukin-6SARS-CoV-2Interleukin-8COVID-19COVID Cardiometabolic Diabetes Inflammation MolecularInterleukin-10Interferon-gammaAdipokinesDiabetes Mellitus Type 2Cardiovascular DiseasesCytokinesHumansInterleukin-2RNA ViralMolecular MedicineInterleukin-4ObesityPandemicsMolecular BiologyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated an…

2009

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with a very poor 5-year survival rate. alpha-Enolase is a glycolytic enzyme that also acts as a surface plasminogen receptor. We find that it is overexpressed in PDAC and present on the cell surface of PDAC cell lines. The clinical correlation of its expression with tumor status has been reported for lung and hepatocellular carcinoma. We have previously demonstrated that sera from PDAC patients contain IgG autoantibodies to alpha-enolase. The present work was intended to assess the ability of alpha-enolase to induce antigen-specific T cell responses. We show that alpha-enolase-pulsed dendritic cells (DC) specifically stimulate healt…

KeratinocytesCancer ResearchPancreatic diseaseendocrine system diseasesalpha-enolaseAntibodies NeoplasmAlpha-enolaseT-LymphocytesMiceSkinImmunity Cellularhuman; pancreatic ductal adenocarcinoma; alpha enolase; tumor antigen; B cell response; T cell responsebiologyalpha enolasehuman; pancreatic ductal adenocarcinoma; alpha-enolase; tumor antigen; B cell response; T cell responseImmunohistochemistryTumor antigenUp-RegulationGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyAntibodyCarcinoma Pancreatic DuctalB cell responseT cellBlotting Westernpancreatic ductal adenocarcinomaGene Expression Regulation EnzymologicInterferon-gammaImmune systemAntigenAntigens NeoplasmCell Line TumorPancreatic cancermedicineAnimalsHumanshumanPancreasCell ProliferationDendritic Cellsmedicine.diseaseT cell responsepancreatic ductal adenocarcinoma; alpha-enolase; tumor antigen.digestive system diseasesPancreatic NeoplasmsImmunoglobulin GPhosphopyruvate HydrataseAntibody FormationImmunologybiology.proteintumor antigenT-Lymphocytes Cytotoxic
researchProduct

Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation

2013

Abstract Epidermal keratinocytes (KCs) and cannabinoid (CB) receptors both participate in the regulation of inflammatory responses in a mouse model for allergic contact dermatitis, the contact hypersensitivity (CHS) response to the obligate sensitizer 2,4-dinitrofluorobenzene. In this study, we investigated the cellular and molecular mechanisms how CB1 receptors attenuate CHS responses to 2,4-dinitrofluorobenzene. We used a conditional gene-targeting approach to identify the relative contribution of CB1 receptors on epidermal KCs for the control of CHS responses. To determine the underlying cellular and molecular mechanisms that regulate inflammatory responses in the effector phase of CHS, …

KeratinocytesChemokineImmunologyInflammationStimulationBiologyProinflammatory cytokineAllergic inflammationInterferon-gammaMiceReceptor Cannabinoid CB1medicineAnimalsChemokine CCL8Immunology and AllergyCXCL10ReceptorCells CulturedCell ProliferationInflammationMice Knockoutintegumentary systemEarAdoptive TransferChemokine CXCL10Mice Inbred C57BLDermatitis Allergic ContactImmunologyChemokine secretionbiology.proteinDinitrofluorobenzenemedicine.symptomThe Journal of Immunology
researchProduct

Unexpected role of natural killer cell-derived interferon-γ as a driver of NETosis and DVT.

2018

Killer Cells NaturalVenous ThrombosisInterferon-gammamedicine.anatomical_structureInterferon γChemistrymedicineCancer researchHumansHematologyExtracellular TrapsNatural killer cellJournal of thrombosis and haemostasis : JTH
researchProduct

Langerhans cells are negative regulators of the anti-Leishmania response

2011

Langerhans cells suppress the immune response to low-dose Leishmania major infection in part by inducing regulatory T cells.

LangerinT cellImmunologyPriming (immunology)Leishmaniasis Cutaneouschemical and pharmacologic phenomenaT-Lymphocytes RegulatoryImmune toleranceInterferon-gammaMiceImmune systemSDG 3 - Good Health and Well-beingparasitic diseasesmedicineImmune ToleranceImmunology and AllergyAnimalsInterferon gammaLeishmania majorLeishmaniasis VaccinesLeishmania majorbiologyintegumentary systemBrief Definitive ReportFOXP3hemic and immune systemsbiochemical phenomena metabolism and nutritionTh1 Cellsbiology.organism_classificationDisease Models Animalmedicine.anatomical_structureLangerhans CellsImmunologybiology.proteinmedicine.drug
researchProduct

Distinct Roles for IL-1 Receptor Type I Signaling in Early Versus Established Leishmania major Infections

2006

IL-1alpha/beta released by infected dendritic cells (DC) plays a critical role in the development of protective immunity against Leishmania major. Previous studies demonstrated that treatment of susceptible BALB/c mice with IL-1alpha during T-cell priming (days 1-3 post-infection) induced T helper (Th)1-mediated protection. In contrast, we now demonstrate that prolonged treatment with IL-1alpha (for 3 weeks) worsened disease outcome. To characterize the receptor involved, L. major infections in IL-1 receptor type I (IL-1RI) knockout mice were studied. In C57BL/6 IL-1RI-/- mice, the IL-1alpha-mediated protective effect was abrogated. The course of high-dose infection (2 x 10(5) parasites) in…

Leishmaniasis CutaneousPriming (immunology)DermatologyReceptor typeBiochemistryInterferon-gammaMiceTh2 CellsmedicineAnimalsParasite hostingLeishmania majorL-SelectinReceptorMolecular BiologyLeishmania majorMice KnockoutReceptors Interleukin-1 Type IMice Inbred BALB CbiologyReceptors Interleukin-1LeishmaniasisT-Lymphocytes Helper-InducerCell BiologyTh1 Cellsbiology.organism_classificationmedicine.diseaseMice Inbred C57BLGene Expression RegulationCD4 AntigensImmunologyKnockout mouseDisease ProgressionInterleukin-4Ex vivoInterleukin-1Signal TransductionJournal of Investigative Dermatology
researchProduct